Nicotinamide riboside as a neuroprotective therapy for glaucoma: study protocol for a randomized, double-blind, placebo-control trial.

Christopher Kai Shun LeungSeraph Tianmin RenPoemen Pui Man ChanKelvin Ho Nam WanAziz Ka Wai KamGilda Wing Ki LaiVivian Sheung Man ChiuMatch Wai Lun KoCedric Ka Fai YiuMarco Chak Yan Yu

Published in: Trials (2022)

Chinese Clinical Trial Registry 1900021998.

Keyphrases

double blind
clinical trial
placebo controlled
phase iii
phase ii
cerebral ischemia
study protocol
optic nerve
open label
subarachnoid hemorrhage